The American Hospital Association (AHA) is pushing back forcefully against the Health Resources and Services Administration’s (HRSA) new 340B rebate [...] …
Category: Federal
A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...] …
The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...] …
The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...] …
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...] …
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...] …
A federal judge in Washington, D.C. has rejected a University of Alabama Health System lawsuit seeking interest on Medicare’s lump [...] …
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...] …
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...] …
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...] …